Assistant Professor, Medicine-Massachusetts General Hospital, Harvard Medical School
Endocrinology
Dr. Hideo Makimura, MD
|
|
Give Review
Hideo Makimura works in the field of Endocrinology. He went to Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20/62 in Research/PrimaryCare. He over the years received 2 awards: "Early Investigators Award" and "Presidential Poster Prize". Hideo Makimura, MD is a published physician. He has 32 publications published. The most current publication "FNDC5 relates to skeletal muscle IGF-I and mitochondrial function and gene expression in obese men with reduced growth hormone." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- FNDC5 relates to skeletal muscle IGF-I and mitochondrial function and gene expression in obese men with reduced Growth hormone.
- Relationship between Serum IGF-I and Skeletal Muscle IGF-I mRNA Expression to Phosphocreatine Recovery after Exercise in Obese Men with Reduced GH.
- Discordance of IGF-1 and GH stimulation testing for altered GH secretion in Obesity.
- The Effects of Tesamorelin on Phosphocreatine Recovery in Obese Subjects with Reduced GH.
- Central Diabetes Insipidus: A Previously Unreported Side Effect of Temozolomide.
- Metabolic effects of a Growth hormone-releasing factor in obese subjects with reduced Growth hormone secretion: a randomized controlled trial.
- Reduced Growth hormone secretion in obesity is associated with smaller LDL and HDL particle size.
- Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a Growth hormone releasing factor.
- Obesity: Cure Obesity: sleep more, eat out less and turn down the heat?
- Increased skeletal muscle phosphocreatine recovery after sub-maximal exercise is associated with increased carotid intima-media thickness.
- The association of Growth hormone parameters with skeletal muscle phosphocreatine recovery in adult men.
- TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabol...
- Effects of a Growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.
- The relationship between reduced testosterone, stimulated Growth hormone secretion and increased carotid intima-media thickness in obese men.
- Skeletal muscle phosphocreatine recovery after submaximal exercise in children and young and middle-aged adults.
- Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation.
- Reduced Growth hormone secretion is associated with increased carotid intima-media thickness in obesity.
- Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients.
- Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects.
- Retinol-binding protein levels are increased in association with gonadotropin levels in healthy women.
- The effects of central adiposity on Growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men.
- Impaired glucose signaling as a cause of obesity and the metabolic Syndrome: the glucoadipostatic hypothesis.
- Obesity over the life course.
- The physiological function of the agouti-related peptide gene: the control of weight and metabolic rate.
- Role of glucocorticoids in mediating effects of fasting and Diabetes on hypothalamic gene expression.
- Adrenalectomy stimulates hypothalamic proopiomelanocortin expression but does not correct diet-induced obesity.
- Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake.
- Adiponectin is stimulated by Adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA.
- Block the FAS, lose the fat.
- Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block ...
- Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice.
Schools
MT SINAI SCH OF MED OF NY UNIV
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Conditions Treated
- Acromegaly and Gigantism
- Adrenal Incidentaloma
- Adrenal Insufficiency
- Cushing's Syndrome
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- Choice Care PPO
- Medicare MCR
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Early Investigators Award
- Presidential Poster Prize
Education
-
Massachusetts General Hospital -
Beth Israel Deaconess Medical Center -
Icahn School of Medicine at Mount Sinai
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1063444594 | |
| NPPES Provider LastName | MAKIMURA | |
| NPPES Provider FirstName | HIDEO | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 94.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063444594 |
| Last Name Of The Provider | MAKIMURA |
| First Name Of The Provider | HIDEO |
| View All |
Similar Doctors
|
|
Dr. Deepanwita Prusty, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samara Pena, MD
This Doctor is OpenDoctor Recommended.
|